United StatesAffirming support for most-favored-Nation drug pricing for United States patients.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Adopted
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Dec 4Submitted in HouseLatest
- Dec 4Referred to the House Committee on Energy and Commerce.Introduced